Show simple item record

Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay

dc.contributor.authorFarren, TW
dc.contributor.authorSadanand, KS
dc.contributor.authorAgrawal, SG
dc.date.accessioned2021-01-12T13:24:08Z
dc.date.available2020-10-26
dc.date.available2021-01-12T13:24:08Z
dc.date.issued2020-12-03
dc.identifier.issn2234-943X
dc.identifier.otherARTN 597730
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/69621
dc.relation.ispartofFRONTIERS IN ONCOLOGY
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectCD160en_US
dc.subjectROR-1en_US
dc.subjectminimalen_US
dc.subjectmeasurable residual diseaseen_US
dc.subjectchronic lymphocytic leukemiaen_US
dc.subjectmonoclonal B-cell lymphocytosisen_US
dc.subjectflow cytometryen_US
dc.subjectimmunophenotypingen_US
dc.titleHighly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assayen_US
dc.typeArticleen_US
dc.identifier.doi10.3389/fonc.2020.597730
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000599283500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume10en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States